As the COVID-19 pandemic continues, King & Spalding continues to assist clients with regulatory and commercial developments to safeguard our clients’ objectives and provide workable solutions to the evolving pressures they face.
King & Spalding’s Digital Health Group has extensive experience guiding Companies, from start-ups to global corporations, through a myriad of considerations as the delivery of healthcare becomes increasingly digital.
The K&S managed care team is well-positioned to counsel clients on compliance with the No Surprises Act, and to navigate the legislation’s impact on their day-to-day operations.
King & Spalding partner Mark Polston discusses hospital price transparency.Watch Now
K&S launches General Counsel Internal Investigations Decision Tree for the Life Sciences industry, including COVID-19 considerations.Explore Here
At this critical juncture of distribution, our COVID-19 Vaccine Rollout Task Force is drawing on our industry knowledge and client relationships to serve as a guiding light and partner to our clients.Read More
King & Spalding partners Sally Yates and Mike Paulhus discuss key developments in healthcare fraud and abuse enforcement.Watch Now
King & Spalding partner John Barnes discusses best practices when negotiating agreements between healthcare providers and commercial payors.Watch Now
King & Spalding partner Amanda Hayes-Kibreab explains ways that healthcare providers can successfully challenge commercial payors’ reimbursement policies.Watch Now
King & Spalding’s Sunshine and State Law Compliance Group serves as a powerful industry advocate with respect to transparency laws for more than 100 members companies.
The K&S International Ad Hoc Group is a coalition of 20+ pharma and medical device companies that focuses on international transparency/disclosure laws targeting manufacturers.
In response to policy changes with healthcare transparency laws, King & Spalding established the Surprise Billing and Price Transparency Group to assist our clients in developing solutions to these new requirements.
Stephanie has significant experience assisting health systems, hospitals, home health and hospice companies, skilled nursing facilities, laboratories and inpatient rehabilitation facilities with compliance program assessments and the negotiation and implementation of Corporate Integrity Agreements.Read More
LMG Life Sciences
October 11, 2021
Health Headlines – October 11, 2021
October 4, 2021
Health Headlines – October 4, 2021
August 24, 2021
Arbor Pharmaceuticals to Merge with Azurity Pharmaceuticals
August 11, 2021
Sharecare Acquires Digital On-Demand Platform CareLinx